Rapamycin-Induced Feedback Activation of eIF4E-EIF4A Dependent mRNA Translation in Pancreatic Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Pancreatic cancer cells utilize protein synthesis pathways to promote tumor growth.
• The mechanistic target of rapamycin (mTOR) pathway is crucial for regulating protein synthesis and cell proliferation.
• Understanding mRNA translation control is vital for developing effective pancreatic cancer therapies.

Purpose of the Study:

• To investigate the specific and genome-wide effects of the mTOR inhibitor rapamycin on mRNA translation in pancreatic cancer cells lacking 4EBP1.
• To identify translation programs modulated by mTOR inhibition and elucidate feedback mechanisms.
• To evaluate the therapeutic potential of targeting translation downstream of mTOR in pancreatic cancer.

Main Methods:

• Ribosome footprinting was employed to analyze mRNA translation in pancreatic cancer cells.
• Rapamycin was used to inhibit the mTOR pathway.
• Specific inhibitors of eIF4E and eIF4A were used in combination with rapamycin.

Main Results:

• Rapamycin selectively inhibited the translation of specific mRNAs, including those encoding p70-S6K, cell cycle proteins, and cancer growth factors.
• mTOR inhibition led to the translational activation of kinases like p90-RSK1 and feedback upregulation of phospho-AKT1 and phospho-eIF4E.
• Combined inhibition of mTOR, eIF4E, and eIF4A resulted in significant growth inhibition of pancreatic cancer cells.

Conclusions:

• mTOR inhibition impacts specific mRNA translation and activates feedback pathways involving AKT-RSK1-eIF4E signaling in 4EBP1-deficient pancreatic cancer cells.
• Targeting translation downstream of mTOR, particularly eIF4E and eIF4A, represents a promising therapeutic strategy for pancreatic cancer.
• This research provides insights into the complex regulation of protein synthesis in pancreatic cancer and identifies potential therapeutic vulnerabilities.